Washington University in St. Louis (WU)
My research is centered on the pathogenesis of HIV metabolic syndrome. The majority of patients who receive treatment for HIV develop a pro-atherogenic metabolic syndrome characterized by high plasma triglycerides, low HDL cholesterol, glucose intolerance, hypertension and truncal obesity. It is likely that HIV, genetic factors and antiretroviral treatment all play a role. I also perform clinical trials examining the effects of lifestyle and drug interventions for the treatment of HIV-metabolic syndrome and non-HIV related metabolic syndrome.
In the clinical arena I am the Director of the Nutrition Support Service which provides nutrition support to medical inpatients. I also manage older adults with diabetes mellitus.